UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rituximab Maintenance Treatment of Relapsed/Resistant Follicular Non-Hodgkin's Lymphoma: Long-Term Outcome of the EORTC 20981 Phase III Randomized Intergroup Study

Journal of clinical oncology, 2010-06, Vol.28 (17), p.2853-2858

2010

Volltextzugriff (PDF)

Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party

Haematologica (Roma), 2013-07, Vol.98 (7), p.1014-1021

2013

Volltextzugriff (PDF)

Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety

Journal of clinical oncology, 2018-08, Vol.36 (23), p.2395-2404

2018

Volltextzugriff (PDF)

BCL-2/IgH Polymerase Chain Reaction Status at the End of Induction Treatment Is Not Predictive for Progression-Free Survival in Relapsed/Resistant Follicular Lymphoma: Results of a Prospective Randomized EORTC 20981 Phase III Intergroup Study

Journal of clinical oncology, 2010-05, Vol.28 (13), p.2246-2252

2010

Volltextzugriff (PDF)

Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial

Blood, 2006-11, Vol.108 (10), p.3295-3301

2006

Volltextzugriff (PDF)

HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era

AIDS (London), 2014-03, Vol.28 (5), p.689-697

2014

Volltextzugriff (PDF)

Risk Factors for and Outcomes of Follicular Lymphoma Histological Transformation at First Progression in the GALLIUM Study

Clinical lymphoma, myeloma and leukemia, 2023-01, Vol.23 (1), p.40-48

2023

Volltextzugriff (PDF)

Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long‐term follow‐up of a prospective study

British journal of haematology, 2003-05, Vol.121 (3), p.462-468

2003

Volltextzugriff (PDF)

Haematopoietic stem cell transplantation does not retard disease progression in the psycho-cognitive variant of late-onset metachromatic leukodystrophy

Journal of inherited metabolic disease, 2010-12, Vol.33 (Suppl 3), p.471-475

2010

Volltextzugriff (PDF)

Follicular lymphoma: time for a re-think?

Blood reviews, 2005-05, Vol.19 (3), p.165-178

2005

Volltextzugriff (PDF)

Anthracycline-based chemotherapy as first-line treatment in adults with malignant posttransplant lymphoproliferative disorder after solid organ transplantation

Transplantation, 2006-08, Vol.82 (3), p.375-381

2006

Volltextzugriff (PDF)

Arthropoda: Tardigrada

E. Marcus, Heinz Wermuth, Robert Mertens, Franz Eilhard Schulze, Richard Hesse, Deutsche Zoologische Gesellschaft / E. Marcus, Heinz Wermuth, Robert Mertens, Franz Eilhard Schulze, Richard Hesse, Deutsche Zoologische Gesellschaft

2011

Volltextzugriff (PDF)

Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation

Blood, 2003-11, Vol.102 (9), p.3427-3438

2003

Volltextzugriff (PDF)

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

The lancet oncology, 2018-11, Vol.19 (11), p.1530-1542

2018

Volltextzugriff (PDF)

Risk Factors and Outcomes of Patients with Follicular Lymphoma Who Had Histologic Transformation at First Progression after First-Line Immunochemotherapy in the Gallium Study

Blood, 2019-11, Vol.134 (Supplement_1), p.5268-5268

2019

Volltextzugriff (PDF)

Invasive fungal sinusitis in patients treated with fludarabine

The Journal of infection, 2008-02, Vol.56 (2), p.156-158

2008

Volltextzugriff (PDF)

Evaluation of the m7-FLIPI in Patients with Follicular Lymphoma Treated within the Gallium Trial: EZH2 mutation Status May be a Predictive Marker for Differential Efficacy of Chemotherapy

Blood, 2019-11, Vol.134 (Supplement_1), p.122-122

2019

Volltextzugriff (PDF)

Autoimmune hemolytic anemia: magnetic resonance findings

Magnetic resonance imaging, 2004-10, Vol.22 (8), p.1153-1155

2004

Volltextzugriff (PDF)

Minimal Residual Disease in Patients with Follicular Lymphoma Treated with Obinutuzumab or Rituximab As First-Line Induction Immunochemotherapy and Maintenance in the Phase 3 GALLIUM Study

Blood, 2016-12, Vol.128 (22), p.613-613

2016

Volltextzugriff (PDF)

Autologous Stem Cell Transplantation Achieves Long-Term Survival in a Selected CNS Lymphoma Population

Blood, 2014-12, Vol.124 (21), p.1197-1197

2014

Volltextzugriff (PDF)

Outcome of BEAM-Autologous and BEAM-Alemtuzumab Allogeneic Transplantation in Relapsed Advanced Stage Follicular Lymphoma

Blood, 2012-11, Vol.120 (21), p.2022-2022

2012

Volltextzugriff (PDF)

Obinutuzumab (GA101) in Combination with FC or CHOP in Patients with Relapsed or Refractory Follicular Lymphoma: Final Results of the Phase I GAUDI Study (BO21000)

Blood, 2011-11, Vol.118 (21), p.270-270

2011

Volltextzugriff (PDF)

Adverse Effect of Very Poor Cytogenetics and Monosomal Karyotype On Outcomes Following T-Deplete Reduced Intensity Conditioned Stem Cell Transplant for MDS and AML

Blood, 2012-11, Vol.120 (21), p.3141-3141

2012

Volltextzugriff (PDF)

1 – 25 von 1.907

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.663)
Mit Volltextzugriff
(1.531)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.222)
Life Sciences & Biomedicine
(999)
Humans
(870)
Male
(504)
Female
(500)
Adult
(321)
Biological And Medical Sciences
(320)
Middle Aged
(306)
Medical Sciences
(288)
Animals
(218)
Aged
(215)
Adolescent
(117)
Neurosciences & Neurology
(112)
Risk Factors
(112)
Child
(111)
Treatment Outcome
(111)
General & Internal Medicine
(107)
Science & Technology - Other Topics
(105)
Surgery
(101)
Oncology
(99)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Rituximab Maintenance Treatment of Relapsed/Resistant Follicular Non-Hodgkin's Lymphoma: Long-Term Outcome of the EORTC 20981 Phase III Randomized Intergroup Study

Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party

Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety

BCL-2/IgH Polymerase Chain Reaction Status at the End of Induction Treatment Is Not Predictive for Progression-Free Survival in Relapsed/Resistant Follicular Lymphoma: Results of a Prospective Randomized EORTC 20981 Phase III Intergroup Study

Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial

HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era

Risk Factors for and Outcomes of Follicular Lymphoma Histological Transformation at First Progression in the GALLIUM Study

Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long‐term follow‐up of a prospective study

Haematopoietic stem cell transplantation does not retard disease progression in the psycho-cognitive variant of late-onset metachromatic leukodystrophy

Follicular lymphoma: time for a re-think?

Anthracycline-based chemotherapy as first-line treatment in adults with malignant posttransplant lymphoproliferative disorder after solid organ transplantation

Arthropoda: Tardigrada

Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Risk Factors and Outcomes of Patients with Follicular Lymphoma Who Had Histologic Transformation at First Progression after First-Line Immunochemotherapy in the Gallium Study

Invasive fungal sinusitis in patients treated with fludarabine

Evaluation of the m7-FLIPI in Patients with Follicular Lymphoma Treated within the Gallium Trial: EZH2 mutation Status May be a Predictive Marker for Differential Efficacy of Chemotherapy

Autoimmune hemolytic anemia: magnetic resonance findings

Minimal Residual Disease in Patients with Follicular Lymphoma Treated with Obinutuzumab or Rituximab As First-Line Induction Immunochemotherapy and Maintenance in the Phase 3 GALLIUM Study

Outcomes for Elderly Patients (pts) with Follicular Lymphoma (FL) Using Individual Patient Data (IPD) from 5922 Pts in 18 Randomized Controlled Trials (RCTs): a Follicular Lymphoma Analysis of Surrogate Hypothesis (FLASH) Group Study

Autologous Stem Cell Transplantation Achieves Long-Term Survival in a Selected CNS Lymphoma Population

Obinutuzumab-Based Induction and Maintenance Prolongs Progression-Free Survival (PFS) in Patients with Previously Untreated Follicular Lymphoma: Primary Results of the Randomized Phase 3 GALLIUM Study

Outcome of BEAM-Autologous and BEAM-Alemtuzumab Allogeneic Transplantation in Relapsed Advanced Stage Follicular Lymphoma

Obinutuzumab (GA101) in Combination with FC or CHOP in Patients with Relapsed or Refractory Follicular Lymphoma: Final Results of the Phase I GAUDI Study (BO21000)

Adverse Effect of Very Poor Cytogenetics and Monosomal Karyotype On Outcomes Following T-Deplete Reduced Intensity Conditioned Stem Cell Transplant for MDS and AML

Suchergebnisse filtern